Journal: Journal of Advanced Research
Article Title: Spike RBD drives sustained Parkinson’s disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation
doi: 10.1016/j.jare.2025.07.060
Figure Lengend Snippet: RTP801 is critical for PD deterioration induced by RBD. (A) Schematic of the αSyn A53T + ; RTP801 −/− mice experiment. (B) Assessment of olfactory dysfunction was conducted using the BFPT and the visible BFPT. (C) A modified open field test with nuts or paprika quantified olfactory acuity. (D-F) Motor coordination and balance were evaluated using the rotarod (D) , pole (E) , and beam walking (F) tests. ( G ) Forelimb grip strength was gauged through the grip strength test. ( H ) The open field test appraised anxiety-related behaviors, tracking total distance traveled, center zone activity. (I-J) Recognition memory was assessed using Y maze test and NORT. Alternation index (% of total triplet arm entries) was quantified in (I) . New object index was quantified in ( J ) (n = 6). (K) Representative images of TH immunostaining in the SNc and striatum and quantitative assessment (all values were normalized relative to αSyn A53T group), scale bar = 500 μm, n = 4. (L) Western blot analysis of TH expression in SNc and striatum and quantitative analysis (n = 4). (M) Colocalization of RTP801 with TH, scale bar = 200 μm. (N) ThS staining quantifies aggregates in the SNc, including ThS signal density, and the proportion of cells inclusive ThS + puncta (n = 4), scale bar = 5 μm. (O) Western blot detection of αSyn aggregation using the 5G4 antibody, with quantitative analysis confirming significant changes (n = 4). ( P ) Analysis of αSyn partitioning in soluble and insoluble brain fractions by western blot, with quantitative data indicating significant alterations (n = 4). Data are expressed as means ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, ns, not significant.
Article Snippet: The membranes were then blocked using 5 % BSA in TBST and incubated overnight at 4 °C with the following primary antibodies: TH (1:500, Santa Cruz, sc-25269), 5G4 (1:1000, Sigma-Aldrich, MABN389), αSyn (1:1000, Abcam, ab138501), cGAS (1:500, Proteintech, 26416–1-AP), STING (1:2000, Proteintech, 19851–1-AP), TBK1 (1:1000, Proteintech, 28397–1-AP;), p-TBK1 (1:1000, Cell Signaling Technology, 5483S), IRF3 (1:5000, Proteintech, 66670–1-Ig), p-IRF3 (1:1000, Cell Signaling Technology, 29047S), RTP801 (1:1000, NOVUS, NBP1-77321) and β-actin (1:10000, ABclonal, AC026), followed by secondary antibodies (1:5000, KPL, Maryland, USA) at room temperature for 2 h. Protein bands were visualized using an Image Quant LAS 4000 mini (GE, Boston, USA), and their intensities were quantified using ImageJ software (Maryland, USA).
Techniques: Olfactory, Modification, Activity Assay, Immunostaining, Western Blot, Expressing, Staining